Literature DB >> 29989427

Current understanding of trigeminal ganglion structure and function in headache.

Karl Messlinger1, Andrew F Russo2,3.   

Abstract

INTRODUCTION: The trigeminal ganglion is unique among the somatosensory ganglia regarding its topography, structure, composition and possibly some functional properties of its cellular components. Being mainly responsible for the sensory innervation of the anterior regions of the head, it is a major target for headache research. One intriguing question is if the trigeminal ganglion is merely a transition site for sensory information from the periphery to the central nervous system, or if intracellular modulatory mechanisms and intercellular signaling are capable of controlling sensory information relevant for the pathophysiology of headaches.
METHODS: An online search based on PubMed was made using the keyword "trigeminal ganglion" in combination with "anatomy", "headache", "migraine", "neuropeptides", "receptors" and "signaling". From the relevant literature, further references were selected in view of their relevance for headache mechanisms. The essential information was organized based on location and cell types of the trigeminal ganglion, neuropeptides, receptors for signaling molecules, signaling mechanisms, and their possible relevance for headache generation.
RESULTS: The trigeminal ganglion consists of clusters of sensory neurons and their peripheral and central axon processes, which are arranged according to the three trigeminal partitions V1-V3. The neurons are surrounded by satellite glial cells, the axons by Schwann cells. In addition, macrophage-like cells can be found in the trigeminal ganglion. Neurons express various neuropeptides, among which calcitonin gene-related peptide is the most prominent in terms of its prevalence and its role in primary headaches. The classical calcitonin gene-related peptide receptors are expressed in non-calcitonin gene-related peptide neurons and satellite glial cells, although the possibility of a second calcitonin gene-related peptide receptor in calcitonin gene-related peptide neurons remains to be investigated. A variety of other signal molecules like adenosine triphosphate, nitric oxide, cytokines, and neurotrophic factors are released from trigeminal ganglion cells and may act at receptors on adjacent neurons or satellite glial cells.
CONCLUSIONS: The trigeminal ganglion may act as an integrative organ. The morphological and functional arrangement of trigeminal ganglion cells suggests that intercellular and possibly also autocrine signaling mechanisms interact with intracellular mechanisms, including gene expression, to modulate sensory information. Receptors and neurotrophic factors delivered to the periphery or the trigeminal brainstem can contribute to peripheral and central sensitization, as in the case of primary headaches. The trigeminal ganglion as a target of drug action outside the blood-brain barrier should therefore be taken into account.

Entities:  

Keywords:  CGRP; Trigeminal neurons; neuromodulation; neuropeptides; satellite glial cells; signaling

Year:  2018        PMID: 29989427      PMCID: PMC7007999          DOI: 10.1177/0333102418786261

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  139 in total

1.  Delta-opioid receptor-immunoreactive neurons in the rat cranial sensory ganglia.

Authors:  H Ichikawa; S Schulz; V Höllt; T Sugimoto
Journal:  Brain Res       Date:  2005-05-10       Impact factor: 3.252

2.  Ultrastructure of glial cells in the human fetal trigeminal ganglion.

Authors:  M Bruska; W Woźniak
Journal:  Folia Morphol (Warsz)       Date:  1991       Impact factor: 1.183

3.  Histochemical evidence for microglia-like macrophages in the rat trigeminal ganglion.

Authors:  J A Glenn; J B Sonceau; H J Wynder; W E Thomas
Journal:  J Anat       Date:  1993-12       Impact factor: 2.610

4.  PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.

Authors:  Inger Jansen-Olesen; Michael Baun; Dipak V Amrutkar; Roshni Ramachandran; Daniel V Christophersen; Jes Olesen
Journal:  Neuropeptides       Date:  2014-01-25       Impact factor: 3.286

Review 5.  ASICs as therapeutic targets for migraine.

Authors:  Greg Dussor
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

6.  5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase.

Authors:  M Hou; M Kanje; J Longmore; J Tajti; R Uddman; L Edvinsson
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

7.  Referral of pain from dural stimulation in man.

Authors:  F P Wirth; J M Van Buren
Journal:  J Neurosurg       Date:  1971-05       Impact factor: 5.115

8.  In situ imaging reveals properties of purinergic signalling in trigeminal sensory ganglia in vitro.

Authors:  Arletta Nowodworska; Arn M J M van den Maagdenberg; Andrea Nistri; Elsa Fabbretti
Journal:  Purinergic Signal       Date:  2017-08-18       Impact factor: 3.765

9.  Free nerve ending terminal morphology is fiber type specific for A delta and C fibers innervating rabbit corneal epithelium.

Authors:  M B MacIver; D L Tanelian
Journal:  J Neurophysiol       Date:  1993-05       Impact factor: 2.714

10.  The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization. A case series of 757 patients.

Authors:  P Barbanti; C Aurilia; V Dall'Armi; G Egeo; L Fofi; S Bonassi
Journal:  Cephalalgia       Date:  2016-02-08       Impact factor: 6.292

View more
  30 in total

1.  Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.

Authors:  Anne-Sophie Wattiez; Levi P Sowers; Andrew F Russo
Journal:  Expert Opin Ther Targets       Date:  2020-02-13       Impact factor: 6.902

2.  NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in mice.

Authors:  Katarzyna M Targowska-Duda; Akihiko Ozawa; Zachariah Bertels; Andrea Cippitelli; Jason L Marcus; Hanna K Mielke-Maday; Gilles Zribi; Amanda N Rainey; Brigitte L Kieffer; Amynah A Pradhan; Lawrence Toll
Journal:  Neuropharmacology       Date:  2020-03-06       Impact factor: 5.250

Review 3.  Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP.

Authors:  Diana N Krause; Karin Warfvinge; Kristian Agmund Haanes; Lars Edvinsson
Journal:  Nat Rev Neurol       Date:  2021-09-20       Impact factor: 42.937

Review 4.  Therapeutic potential for P2Y2 receptor antagonism.

Authors:  Kimberly J Jasmer; Kevin Muñoz Forti; Lucas T Woods; Seunghee Cha; Gary A Weisman
Journal:  Purinergic Signal       Date:  2022-10-11       Impact factor: 3.950

5.  Low-dose interleukin-2 reverses chronic migraine-related sensitizations through peripheral interleukin-10 and transforming growth factor beta-1 signaling.

Authors:  Zhaohua Guo; Jintao Zhang; Xuemei Liu; Jacqueline Unsinger; Richard S Hotchkiss; Yu-Qing Cao
Journal:  Neurobiol Pain       Date:  2022-06-13

6.  The Responses to CGRP in the Territory of the Posterior Cerebral Artery in Migraine.

Authors:  Darja Visočnik; Marjan Zaletel; Matija Zupan; Bojana Žvan
Journal:  Biomed Res Int       Date:  2022-06-26       Impact factor: 3.246

Review 7.  Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain.

Authors:  Adriana Della Pietra; Juha Savinainen; Rashid Giniatullin
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

8.  Increase in trigeminal ganglion neurons that respond to both calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in mouse models of chronic migraine and posttraumatic headache.

Authors:  Zhaohua Guo; Katherine Czerpaniak; Jintao Zhang; Yu-Qing Cao
Journal:  Pain       Date:  2021-05-01       Impact factor: 7.926

9.  Vascular actions of peripheral CGRP in migraine-like photophobia in mice.

Authors:  Bianca N Mason; Anne-Sophie Wattiez; Louis K Balcziak; Adisa Kuburas; William J Kutschke; Andrew F Russo
Journal:  Cephalalgia       Date:  2020-08-18       Impact factor: 6.292

10.  α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia.

Authors:  Hung-Ruei Tzeng; Ming Tatt Lee; Pi-Chuan Fan; Daniel E Knutson; Tzu-Hsuan Lai; Werner Sieghart; James Cook; Lih-Chu Chiou
Journal:  Neurotherapeutics       Date:  2020-10-27       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.